Detalhe da pesquisa
1.
Osimertinib with Chemotherapy in EGFR-Mutated NSCLC.
N Engl J Med
; 390(5): 478, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38294983
2.
A prospective observational registry evaluating clinical outcomes of Radium-223 treatment in a nonstudy population.
Int J Cancer
; 147(4): 1143-1151, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31875956
3.
Comparability of PD-L1 immunohistochemistry assays for non-small-cell lung cancer: a systematic review.
Histopathology
; 76(6): 793-802, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31793055
4.
Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation.
Prostate
; 76(1): 32-40, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26390914
5.
Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer.
Oncology
; 91(5): 267-273, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27544669
6.
Prognostic Value of Nivolumab Clearance in Non-Small Cell Lung Cancer Patients for Survival Early in Treatment.
Clin Pharmacokinet
; 62(12): 1749-1754, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37856040
7.
Chemotherapy for patients with EGFR-mutated NSCLC after progression on EGFR-TKI's: Exploration of efficacy of unselected treatment in a multicenter cohort study.
Lung Cancer
; 181: 107248, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37216839
8.
Integrated analysis of pain, health-related quality of life, and analgesic use in patients with metastatic castration-resistant prostate cancer treated with Radium-223.
Prostate Cancer Prostatic Dis
; 25(2): 248-255, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34446849